ras peptide cancer vaccine

BIOLOGICAL7 trials

Conditions

Breast CancerCervical CancerColorectal CancerEndometrial CancerExtensive Stage Small Cell Lung CancerHead and Neck CancerLeukemiaLimited Stage Small Cell Lung Cancer

Phase 1

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

CompletedNCT00019591

National Cancer Institute (NCI)Colorectal Cancer

Start: 1999-03-31End: 2005-11-30Updated: 2013-06-20

Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer

CompletedNCT00005630

Memorial Sloan Kettering Cancer CenterLung Cancer

Start: 1999-07-31End: 2002-05-31Updated: 2013-06-19

Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome

CompletedNCT00003959

Memorial Sloan Kettering Cancer CenterLeukemia, Myelodysplastic Syndromes

Start: 1999-06-30Updated: 2013-01-16

Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

CompletedNCT00006387

Fox Chase Cancer CenterColorectal Cancer, Pancreatic Cancer

Start: 2000-10-31End: 2002-01-31Updated: 2013-07-11

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer

CompletedNCT00019006

National Cancer Institute (NCI)Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer, Recurrent Colon Cancer +11

Start: 1995-03-31Updated: 2024-03-04

Phase 2

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

CompletedNCT00019331

National Cancer Institute (NCI)Colorectal Cancer, Endometrial Cancer, Head and Neck Cancer +6

Start: 1997-10-31End: 2007-05-31Updated: 2013-06-20

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer

CompletedNCT00019084

National Cancer Institute (NCI)Breast Cancer, Cervical Cancer, Colorectal Cancer +3

Start: 1996-02-29End: 2003-05-31Updated: 2013-06-20

Related Papers

Results disclosure of papilloma vaccine studies in humans completed before January 1st, 2011.

Figshare2014-01-01